1. PI3K/Akt/mTOR Stem Cell/Wnt Cell Cycle/DNA Damage
  2. GSK-3 CDK
  3. GSK-3 inhibitor 4

GSK-3 inhibitor 4 是一种具有口服活性和脑渗透性的 GSK-3CDK2CDK5的抑制剂,IC50 值分别为 0.56 nM (GSK-3β),0.45 nM (GSK-3α),0.47 μM,0.68 μM。GSK-3 inhibitor 4 能有效降低 Tau protein 水平。GSK-3 inhibitor 4 可用于阿尔茨海默症的研究 (AD)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

GSK-3 inhibitor 4 Chemical Structure

GSK-3 inhibitor 4 Chemical Structure

CAS No. : 2227279-83-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

GSK-3 inhibitor 4 is an orally active and brain-penetrant inhibitor of GSK-3, CDK2, and CDK5, with IC50 values of 0.56 nM (GSK-3β), 0.45 nM (GSK-3α), 0.47 μM, and 0.68 μM, respectively. GSK-3 inhibitor 4 effectively reduces the phosphorylation level of Tau protein. GSK-3 inhibitor 4 can be used in Alzheimer's disease (AD) studies[1].

IC50 & Target

GSK-3α

0.45 nM (IC50)

GSK-3β

0.56 nM (IC50)

CDK2

0.47 μM (IC50)

CDK5

0.68 μM (IC50)

体外研究
(In Vitro)

GSK-3 inhibitor 4 (compound 40) 对 CDK2 (840-fold, IC50 = 0.47 μM),CDK5 (1200-fold, IC50 = 0.68 μM),GSK-3β (IC50 = 0.56 nM),和 GSK-3α (IC50 = 0.45 nM) 表现出极佳的选择性[1]
GSK-3 inhibitor 4具有良好的渗透性,由于其亲脂性,表现出与血浆蛋白和脑组织结合的高能力[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

GSK-3 inhibitor 4 (10 mg/kg, p.o.) 当以 10 mg/kg 的剂量口服纳米悬浮液时,pTau396 减少 37%[1]
GSK-3 inhibitor 4 (2 mg/kg, i.v.; 10 mg/kg, p.o.) 表现出低-中度的清除率,从 15.8 到 23.3 mL/min/kg,以溶液形式口服时吸收良好[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 3xTg mice were bred onto the C57BL6 background and bred as homozygotes. Male animals between the ages of five to seven months were used for the study[1].
Dosage: 10 mg/kg
Administration: Oral gavage (p.o.)
Result: Produced a 37% reduction in pTau396, when administered orally as a nanosuspension at a dose of 10 mg/kg.
Animal Model: male C57BL6 mice (Pharmacokinetic assay)[1]
Dosage: 2 mg/kg, 10 mg/kg.
Administration: Kept for 8 h fasting prior to formulation administration. intravenous and oral routes of administration to mice at a dose of 2 and 10 mg/kg, respectively.
Result: Exhibited clearance ranging from 15.8 to 23.3 mL /min/kg , halflives ranging from 2.5 to 2.9 h and were readily orally bioavailable (F% = 53).
分子量

403.38

Formula

C22H15F2N5O

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
GSK-3 inhibitor 4
目录号:
HY-154852
需求量: